Skip to main content
Friday, September 4, 2026
BTC $81,114 ▲ 4.31%
GOKHSHTEIN.
Live WirePoliticsWorldMarketsDigital AssetsTechnologySports
FranchisesThe BriefThe Big ReadThe BreakdownCrypto Culture
More SectionsDeFi & On-ChainU.S. EquitiesMacro & RatesResearch
Subscribe
Menu
NewsLive WirePoliticsWorldMarketsDigital AssetsTechnologySports
FranchisesThe BriefThe Big ReadThe BreakdownCrypto Culture
MoreDeFi & On-ChainU.S. EquitiesMacro & RatesResearch
Subscribe
LIVE
BTC$81,114up+4.31%ETH$2,525up+5.25%SOL$104.30up+3.90%XRP$1.45up+6.48%LINK$12.06up+7.83%ADA$0.223up+7.60%S&P 5007,748up+1.06%Nasdaq26,584up+1.40%Dow53,686up+1.18%RUT2,968up+0.51%TNX4.76%down−0.71%TYX5.24%down−0.46%FVX4.51%down−0.94%IRX3.74%down−0.85%VIX14.19down−0.91%GOLD$4,522.20down−0.39%SILVER$67.58down−0.19%OIL$90.74down−0.61%DXY99.07up+0.16%NVDA$228.45up+1.80%AAPL$328.21up+1.00%TSLA$376.37up+5.42%META$610.68up+3.01%MSFT$510.12up+2.68%AMZN$258.90up+1.54%GOOGL$342.48up+1.59%Fear & Greed74 — GreedBTC$81,114up+4.31%ETH$2,525up+5.25%SOL$104.30up+3.90%XRP$1.45up+6.48%LINK$12.06up+7.83%ADA$0.223up+7.60%S&P 5007,748up+1.06%Nasdaq26,584up+1.40%Dow53,686up+1.18%RUT2,968up+0.51%TNX4.76%down−0.71%TYX5.24%down−0.46%FVX4.51%down−0.94%IRX3.74%down−0.85%VIX14.19down−0.91%GOLD$4,522.20down−0.39%SILVER$67.58down−0.19%OIL$90.74down−0.61%DXY99.07up+0.16%NVDA$228.45up+1.80%AAPL$328.21up+1.00%TSLA$376.37up+5.42%META$610.68up+3.01%MSFT$510.12up+2.68%AMZN$258.90up+1.54%GOOGL$342.48up+1.59%Fear & Greed74 — Greed
GOKHSHTEIN.
Media · Est. 2019
The front page of everything. Breaking news and sharp analysis across politics, markets, crypto, technology, and sports — with live market data built in.
Markets
Market OverviewDigital AssetsU.S. EquitiesMacro & RatesResearch
Editorial
Politics & PolicyTechnologySports BusinessResearch
Terminal
GMarketsGo PRO
Company
AboutContactThe NetworkEditorial StandardsCorrectionsAdvertiseSubscribe
Legal
Privacy PolicyTerms of ServiceDisclosures
© 2026 Gokhshtein Media. All rights reserved.
PrivacyTermsDisclosures
Tag

m&a

7 articles

Stripe's $7.5B OpenRouter Bet: The Toll Road Through AI Infrastructure
Technology8d ago
Stripe's $7.5B OpenRouter Bet: The Toll Road Through AI Infrastructure
Nine companies chased the AI routing startup. Stripe won by recognizing that metering every enterprise's AI consumption is worth more than processing its payments.
PE's Exit Crisis: 33,575 Unsold Companies Lock Up Limited Partner Cash
U.S. Equities15d ago
PE's Exit Crisis: 33,575 Unsold Companies Lock Up Limited Partner Cash
Private equity's portfolio backlog doubled to 33,575 companies in a decade, blocking distributions to pension funds and endowments while delaying carried-interest payouts to Apollo, Blackstone, KKR and Carlyle
AstraZeneca Explored Acquisition of Bristol Myers Squibb in $400 Billion Deal
Research & Analysis32d ago
AstraZeneca Explored Acquisition of Bristol Myers Squibb in $400 Billion Deal
A combination would create one of the world's largest drugmakers and expand AstraZeneca's footprint in the United States.
Louisville Bidder Presses Brown Family to Reopen Rejected Takeover
U.S. Equities39d ago
Louisville Bidder Presses Brown Family to Reopen Rejected Takeover
The Louisville firm is pushing for direct negotiations after its initial offer failed to win Brown family support, renewing a deal process stalled by shareholder resistance
B2C2 Sale Talks Stall at $1 Billion Valuation
Digital Assets41d ago
B2C2 Sale Talks Stall at $1 Billion Valuation
SBI Holdings' crypto market maker B2C2 held talks with multiple suitors over 18 months, but a $1 billion-plus price tag killed every deal.
TikToker's Spirit Airlines Bid: Social Media's New M&A Frontier or Fleeting Trend?
Technology123d ago
TikToker's Spirit Airlines Bid: Social Media's New M&A Frontier or Fleeting Trend?
A viral TikTok campaign to acquire the distressed Spirit Airlines after its operational collapse highlights the growing influence of social media on capital markets and the potential for retail investor-driven corporate action.
UCB $2.2 Billion Buy Signals M&A Resilience Amid Stable Rates
Macro & Rates123d ago
UCB $2.2 Billion Buy Signals M&A Resilience Amid Stable Rates
Belgian pharma group UCB's substantial acquisition of Candid Therapeutics underscores how prevailing interest rate conditions and broader economic stability are shaping corporate M&A strategies and capital deployment.